3상완료

A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

연구 개요

The purpose of this study is to assess the safety and the body's immune response to an experimental H1N1 influenza vaccine in healthy adult and elderly populations. The study will enroll up to 590 healthy adults ages 18 and older with no history of H1N1 infection or vaccination. 354 individuals will be 18-64 years old, and the other 236 will be greater than or equal to 65 years of age.

스폰서: 리드: GC녹십자
적응증: Influenza Infection
중재: Adjuvanted influenza A(H1N1) vaccine, Adjuvanted influenza A(H1N1) vaccine, un-adjuvanted influenza A(H1N1) vaccine, Adjuvanted influenza A(H1N1) vaccine, Adjuvanted influenza A(H1N1) vaccine
목표 등록: 592명
시작일: 2009-10-01
완료(예정): 2010-07-01
등록번호: NCT01201902 · ClinicalTrials.gov ↗

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.